Live feed12:30:00·2026dPRReleasevia QuantisnowCRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication in the New England Journal of MedicineByQuantisnow·Wall Street's wire, on your screen.VRTX· Vertex Pharmaceuticals IncorporatedCRSP· CRISPR Therapeutics AGHealth CareOriginal source
